These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 18423590)

  • 1. Experiential and genetic contributions to depressive- and anxiety-like disorders: clinical and experimental studies.
    Anisman H; Merali Z; Stead JD
    Neurosci Biobehav Rev; 2008 Aug; 32(6):1185-206. PubMed ID: 18423590
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The pathogenesis of clinical depression: stressor- and cytokine-induced alterations of neuroplasticity.
    Hayley S; Poulter MO; Merali Z; Anisman H
    Neuroscience; 2005; 135(3):659-78. PubMed ID: 16154288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Corticotropin releasing hormone receptor alterations elicited by acute and chronic unpredictable stressor challenges in stressor-susceptible and resilient strains of mice.
    Anisman H; Prakash P; Merali Z; Poulter MO
    Behav Brain Res; 2007 Aug; 181(2):180-90. PubMed ID: 17517441
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stress, depression, and anhedonia: caveats concerning animal models.
    Anisman H; Matheson K
    Neurosci Biobehav Rev; 2005; 29(4-5):525-46. PubMed ID: 15925696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotransmitter, peptide and cytokine processes in relation to depressive disorder: comorbidity between depression and neurodegenerative disorders.
    Anisman H; Merali Z; Hayley S
    Prog Neurobiol; 2008 May; 85(1):1-74. PubMed ID: 18346832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclooxygenase-2 deficiency modifies the neurochemical effects, motor impairment and co-morbid anxiety provoked by paraquat administration in mice.
    Litteljohn D; Mangano EN; Hayley S
    Eur J Neurosci; 2008 Aug; 28(4):707-16. PubMed ID: 18657183
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased levels of cocaine and amphetamine regulated transcript in two animal models of depression and anxiety.
    Wiehager S; Beiderbeck DI; Gruber SH; El-Khoury A; Wamsteeker J; Neumann ID; Petersén A; Mathé AA
    Neurobiol Dis; 2009 May; 34(2):375-80. PubMed ID: 19254763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mice selected for high versus low stress reactivity: a new animal model for affective disorders.
    Touma C; Bunck M; Glasl L; Nussbaumer M; Palme R; Stein H; Wolferstätter M; Zeh R; Zimbelmann M; Holsboer F; Landgraf R
    Psychoneuroendocrinology; 2008 Jul; 33(6):839-62. PubMed ID: 18502051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurobiological consequences of childhood trauma.
    Nemeroff CB
    J Clin Psychiatry; 2004; 65 Suppl 1():18-28. PubMed ID: 14728093
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stress and cytokine-elicited neuroendocrine and neurotransmitter sensitization: implications for depressive illness.
    Hayley S; Merali Z; Anisman H
    Stress; 2003 Mar; 6(1):19-32. PubMed ID: 12637204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stress and anxiety in schizophrenia and depression: glucocorticoids, corticotropin-releasing hormone and synapse regression.
    Bennett A O MR
    Aust N Z J Psychiatry; 2008 Dec; 42(12):995-1002. PubMed ID: 19016087
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PreproNPY Pro7 protects against depression despite exposure to environmental risk factors.
    Sjöholm LK; Melas PA; Forsell Y; Lavebratt C
    J Affect Disord; 2009 Nov; 118(1-3):124-30. PubMed ID: 19264362
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 'Negativity bias' in risk for depression and anxiety: brain-body fear circuitry correlates, 5-HTT-LPR and early life stress.
    Williams LM; Gatt JM; Schofield PR; Olivieri G; Peduto A; Gordon E
    Neuroimage; 2009 Sep; 47(3):804-14. PubMed ID: 19446647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Depression as a consequence of inadequate neurochemical adaptation in response to stressors.
    Anisman H; Zacharko RM
    Br J Psychiatry Suppl; 1992 Feb; (15):36-43. PubMed ID: 1356356
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dysthymia: a review of pharmacological and behavioral factors.
    Griffiths J; Ravindran AV; Merali Z; Anisman H
    Mol Psychiatry; 2000 May; 5(3):242-61. PubMed ID: 10889527
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Behavioral and neurochemical consequences associated with stressors.
    Anisman H; Zacharko RM
    Ann N Y Acad Sci; 1986; 467():205-25. PubMed ID: 3524379
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokines, stressors, and clinical depression: augmented adaptation responses underlie depression pathogenesis.
    Simmons DA; Broderick PA
    Prog Neuropsychopharmacol Biol Psychiatry; 2005 Jun; 29(5):793-807. PubMed ID: 15923072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mapping patterns of depression-related brain regions with cytochrome oxidase histochemistry: relevance of animal affective systems to human disorders, with a focus on resilience to adverse events.
    Harro J; Kanarik M; Matrov D; Panksepp J
    Neurosci Biobehav Rev; 2011 Oct; 35(9):1876-89. PubMed ID: 21382409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term effects of early-life environmental manipulations in rodents and primates: Potential animal models in depression research.
    Pryce CR; Rüedi-Bettschen D; Dettling AC; Weston A; Russig H; Ferger B; Feldon J
    Neurosci Biobehav Rev; 2005; 29(4-5):649-74. PubMed ID: 15925698
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [ADHD and attachment processes: are they related?].
    Franc N; Maury M; Purper-Ouakil D
    Encephale; 2009 Jun; 35(3):256-61. PubMed ID: 19540412
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.